Arc Institute seeks new Investigators--January deadlines--please circulate

[Jaybee00]

Please circulate!!!!

https://arcinstitute.org/jobs/faculty-and-fellows

Arc Investigator Programs
As part of our mission to understand and treat complex human diseases, the Arc Institute is launching searches across three investigator programs. All Arc investigators receive unrestricted, flexible funding to pursue their most important ideas – with complete freedom to study fundamental biological mechanisms, develop new technologies, or innovate on therapeutic concepts. We encourage interdisciplinary collaboration, curiosity-driven exploration, and goal-oriented research.
Applications are open immediately until January 9, 2023 (Science Fellows) and January 31, 2023 (Core Investigators & Innovation Investigators).

 

[Trish]

Looks like this is just for researchers at 3 California universities. Lots of money. I hope some of it goes to ME/CFS research.

 

[Jaybee00]

So there are three programs—only the innovation investigator program is limited to the 3 universities—the other 2 are open to all.

e.g.
Current faculty at all career stages are encouraged to apply, and Arc is excited about the opportunity to support scientists at early career stages (~10 years post-independence or in their postdoctoral training period). Individuals who are authorized to work in the US as well as those who require visa sponsorship are eligible to apply.

 

[Jaybee00]

Thread

 

[SNT Gatchaman]

A little more on the Arc Institute —

The Arc Institute is an independent nonprofit research organisation that operates in collaboration with Stanford University, the University of California, Berkeley, and the University of California, San Francisco. The institute has been established with a USD 650 million fund to allow ongoing scientific investigation into complex human diseases, with a focus on high-risk, high-reward research with potential.

Arc researchers pursue both curiosity-driven exploration and goal-oriented research. The institute will initially focus on complex diseases, including neurodegeneration, cancer, and immune dysfunction. This challenge requires researchers across many disciplines to study fundamental biological mechanisms, develop new technologies, and innovate on therapeutic concepts.

Arc gives scientists no-strings-attached, multi-year funding, so that they don’t have to apply for external grants, and invests in the rapid development of experimental and computational technological tools.

Arc’s mission is to accelerate scientific progress, understand the root causes of disease, and narrow the gap between discoveries and impact on patients.

Some links added for reference (where generalised and available) —

Arc was started by Silvana Konermann, Patrick Hsu, and Patrick Collison.

Arc’s founding donors include Vitalik Buterin, Patrick Collison, John Collison, the Ron Conway family, Crankstart, Elad Gil and Jennifer Huang Gil, Daniel Gross, Dustin Moskovitz and Cari Tuna, and Hemant and Jessica Taneja. They are joined by Matt Berger, Craig Falls, Rob Granieri, James McClave, and Adam Winkel from Jane Street.

The majority of founding donors bring capital from large scale, successful software / Internet endeavours. Personally, I view this as a favourable combination: taking the best elements of the Silicon Valley "move fast and break things" mentality, tempered by experience of deploying robust software engineering methodologies; with early career researchers working in newer biotech areas, such as genomics and gene editing. I imagine many of the donors might have close experience of complex disease and see this as a vehicle to accelerate developments, where national funding bodies are dallying (c.f. US NIH RECOVER).